nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—urine—polycystic ovary syndrome	0.0197	0.146	CbGeAlD
Bupivacaine—Acidosis—Metformin—polycystic ovary syndrome	0.017	0.0606	CcSEcCtD
Bupivacaine—Body temperature decreased—Metformin—polycystic ovary syndrome	0.0167	0.0598	CcSEcCtD
Bupivacaine—Hypothermia—Metformin—polycystic ovary syndrome	0.0167	0.0598	CcSEcCtD
Bupivacaine—CYP1A2—urine—polycystic ovary syndrome	0.0161	0.119	CbGeAlD
Bupivacaine—PTGER1—female gonad—polycystic ovary syndrome	0.0123	0.0913	CbGeAlD
Bupivacaine—Fungal infection—Metformin—polycystic ovary syndrome	0.0122	0.0434	CcSEcCtD
Bupivacaine—CYP3A4—urine—polycystic ovary syndrome	0.0116	0.0862	CbGeAlD
Bupivacaine—Rigors—Metformin—polycystic ovary syndrome	0.0115	0.0411	CcSEcCtD
Bupivacaine—PTGER1—endocrine gland—polycystic ovary syndrome	0.0114	0.0849	CbGeAlD
Bupivacaine—CYP2D6—urine—polycystic ovary syndrome	0.0114	0.0848	CbGeAlD
Bupivacaine—Neuropathy—Metformin—polycystic ovary syndrome	0.00882	0.0315	CcSEcCtD
Bupivacaine—SCN4A—pituitary gland—polycystic ovary syndrome	0.00842	0.0624	CbGeAlD
Bupivacaine—Lightheadedness—Metformin—polycystic ovary syndrome	0.0084	0.03	CcSEcCtD
Bupivacaine—SCN4A—adipose tissue—polycystic ovary syndrome	0.00838	0.0622	CbGeAlD
Bupivacaine—SCN4A—adrenal gland—polycystic ovary syndrome	0.00752	0.0558	CbGeAlD
Bupivacaine—Injury—Metformin—polycystic ovary syndrome	0.00741	0.0265	CcSEcCtD
Bupivacaine—SCN10A—pituitary gland—polycystic ovary syndrome	0.00718	0.0533	CbGeAlD
Bupivacaine—Lethargy—Metformin—polycystic ovary syndrome	0.00695	0.0248	CcSEcCtD
Bupivacaine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00593	0.0212	CcSEcCtD
Bupivacaine—Sweating increased—Metformin—polycystic ovary syndrome	0.00574	0.0205	CcSEcCtD
Bupivacaine—SCN10A—endocrine gland—polycystic ovary syndrome	0.00556	0.0413	CbGeAlD
Bupivacaine—Infestation NOS—Metformin—polycystic ovary syndrome	0.00525	0.0188	CcSEcCtD
Bupivacaine—Drowsiness—Metformin—polycystic ovary syndrome	0.00525	0.0188	CcSEcCtD
Bupivacaine—Infestation—Metformin—polycystic ovary syndrome	0.00525	0.0188	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00515	0.0184	CcSEcCtD
Bupivacaine—Bradycardia—Metformin—polycystic ovary syndrome	0.0048	0.0171	CcSEcCtD
Bupivacaine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00469	0.0168	CcSEcCtD
Bupivacaine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00464	0.0166	CcSEcCtD
Bupivacaine—Flushing—Metformin—polycystic ovary syndrome	0.00438	0.0156	CcSEcCtD
Bupivacaine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00438	0.0156	CcSEcCtD
Bupivacaine—Chills—Metformin—polycystic ovary syndrome	0.00423	0.0151	CcSEcCtD
Bupivacaine—Erythema—Metformin—polycystic ovary syndrome	0.0041	0.0147	CcSEcCtD
Bupivacaine—Malnutrition—Metformin—polycystic ovary syndrome	0.0041	0.0147	CcSEcCtD
Bupivacaine—Flatulence—Metformin—polycystic ovary syndrome	0.00404	0.0144	CcSEcCtD
Bupivacaine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00395	0.0141	CcSEcCtD
Bupivacaine—Vision blurred—Metformin—polycystic ovary syndrome	0.00387	0.0138	CcSEcCtD
Bupivacaine—Tremor—Metformin—polycystic ovary syndrome	0.00385	0.0137	CcSEcCtD
Bupivacaine—Syncope—Metformin—polycystic ovary syndrome	0.00368	0.0131	CcSEcCtD
Bupivacaine—Palpitations—Metformin—polycystic ovary syndrome	0.00363	0.013	CcSEcCtD
Bupivacaine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00361	0.0129	CcSEcCtD
Bupivacaine—Hypertension—Metformin—polycystic ovary syndrome	0.00354	0.0127	CcSEcCtD
Bupivacaine—CYP2C19—vagina—polycystic ovary syndrome	0.00348	0.0258	CbGeAlD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00347	0.0124	CcSEcCtD
Bupivacaine—Oedema—Metformin—polycystic ovary syndrome	0.00335	0.012	CcSEcCtD
Bupivacaine—Infection—Metformin—polycystic ovary syndrome	0.00333	0.0119	CcSEcCtD
Bupivacaine—Shock—Metformin—polycystic ovary syndrome	0.0033	0.0118	CcSEcCtD
Bupivacaine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00329	0.0117	CcSEcCtD
Bupivacaine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00326	0.0242	CbGeAlD
Bupivacaine—Skin disorder—Metformin—polycystic ovary syndrome	0.00325	0.0116	CcSEcCtD
Bupivacaine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00324	0.0116	CcSEcCtD
Bupivacaine—Hypotension—Metformin—polycystic ovary syndrome	0.00313	0.0112	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00305	0.0109	CcSEcCtD
Bupivacaine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00301	0.0107	CcSEcCtD
Bupivacaine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00299	0.0107	CcSEcCtD
Bupivacaine—Somnolence—Metformin—polycystic ovary syndrome	0.00298	0.0106	CcSEcCtD
Bupivacaine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00295	0.0105	CcSEcCtD
Bupivacaine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00291	0.0104	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00289	0.0103	CcSEcCtD
Bupivacaine—Constipation—Metformin—polycystic ovary syndrome	0.00286	0.0102	CcSEcCtD
Bupivacaine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00276	0.00986	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00274	0.00978	CcSEcCtD
Bupivacaine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00266	0.0197	CbGeAlD
Bupivacaine—Urticaria—Metformin—polycystic ovary syndrome	0.00266	0.0095	CcSEcCtD
Bupivacaine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00265	0.00946	CcSEcCtD
Bupivacaine—Asthenia—Metformin—polycystic ovary syndrome	0.0024	0.00858	CcSEcCtD
Bupivacaine—Pruritus—Metformin—polycystic ovary syndrome	0.00237	0.00846	CcSEcCtD
Bupivacaine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00229	0.00818	CcSEcCtD
Bupivacaine—Dizziness—Metformin—polycystic ovary syndrome	0.00222	0.00791	CcSEcCtD
Bupivacaine—Vomiting—Metformin—polycystic ovary syndrome	0.00213	0.00761	CcSEcCtD
Bupivacaine—Headache—Metformin—polycystic ovary syndrome	0.0021	0.00749	CcSEcCtD
Bupivacaine—CYP2D6—female gonad—polycystic ovary syndrome	0.00204	0.0151	CbGeAlD
Bupivacaine—Nausea—Metformin—polycystic ovary syndrome	0.00199	0.0071	CcSEcCtD
Bupivacaine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00193	0.0143	CbGeAlD
Bupivacaine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.0019	0.0141	CbGeAlD
Bupivacaine—PTGER1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000398	0.00068	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000395	0.000675	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000395	0.000674	CbGpPWpGaD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000394	0.000673	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000393	0.000672	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000385	0.000657	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000378	0.000646	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000375	0.000641	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000374	0.000639	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000373	0.000638	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000373	0.000637	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000372	0.000636	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000372	0.000636	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000372	0.000635	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000369	0.00063	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000367	0.000628	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000365	0.000623	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000364	0.000622	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000361	0.000618	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000352	0.000601	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000349	0.000596	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000348	0.000594	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000346	0.000591	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000346	0.000591	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000345	0.00059	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000344	0.000588	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000343	0.000586	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000343	0.000586	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000341	0.000583	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000339	0.00058	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000339	0.00058	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000337	0.000577	CbGpPWpGaD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000333	0.00057	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00033	0.000564	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00032	0.000547	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00032	0.000546	CbGpPWpGaD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000317	0.000542	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000316	0.000539	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000309	0.000528	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000305	0.000521	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000305	0.000521	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000302	0.000516	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000301	0.000514	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000295	0.000504	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000291	0.000497	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000288	0.000492	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000287	0.000491	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000287	0.00049	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000284	0.000486	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000283	0.000484	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000282	0.000482	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.00028	0.000479	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00028	0.000479	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000279	0.000477	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000277	0.000473	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000269	0.00046	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000268	0.000458	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000267	0.000457	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00026	0.000444	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00026	0.000444	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000259	0.000443	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000258	0.000441	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000257	0.00044	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000257	0.000439	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000256	0.000437	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00025	0.000428	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00025	0.000427	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.00025	0.000427	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000248	0.000423	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000247	0.000421	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000245	0.000419	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000245	0.000419	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000242	0.000414	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000242	0.000413	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000241	0.000411	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000238	0.000406	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000234	0.0004	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000229	0.000391	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000228	0.00039	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000227	0.000389	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000227	0.000388	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000227	0.000388	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000227	0.000387	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000226	0.000385	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000226	0.000385	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000224	0.000383	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000223	0.000381	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000219	0.000374	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000218	0.000373	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000215	0.000367	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.00021	0.000358	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000209	0.000357	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000209	0.000357	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000208	0.000356	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000199	0.000341	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000199	0.000341	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000197	0.000337	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000195	0.000333	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000194	0.000331	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000194	0.000331	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000191	0.000327	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000191	0.000327	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.00019	0.000325	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000189	0.000322	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000186	0.000319	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000186	0.000319	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.000185	0.000316	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000183	0.000314	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000183	0.000313	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000181	0.000309	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000178	0.000305	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000178	0.000305	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000178	0.000305	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000178	0.000304	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000177	0.000303	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000174	0.000297	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000162	0.000278	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000162	0.000277	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000161	0.000276	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.00016	0.000273	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000156	0.000267	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000154	0.000263	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000154	0.000263	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000151	0.000258	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000151	0.000258	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000149	0.000255	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000147	0.000252	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000147	0.000252	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000147	0.000251	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000145	0.000248	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000145	0.000248	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000143	0.000244	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000142	0.000242	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000139	0.000238	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000137	0.000234	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000137	0.000234	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000135	0.000231	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000134	0.000229	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—INS—polycystic ovary syndrome	0.000133	0.000228	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000131	0.000224	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000129	0.000221	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000129	0.000221	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000127	0.000216	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000125	0.000213	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000123	0.000211	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000123	0.00021	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.00012	0.000206	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.00012	0.000205	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000117	0.0002	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000117	0.000199	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000117	0.000199	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000115	0.000196	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000114	0.000196	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000114	0.000195	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000113	0.000193	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000111	0.00019	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000108	0.000184	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000105	0.000179	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000102	0.000175	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000102	0.000174	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	9.92e-05	0.00017	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.92e-05	0.00017	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—polycystic ovary syndrome	9.87e-05	0.000169	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.77e-05	0.000167	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	9.73e-05	0.000166	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	9.62e-05	0.000164	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	9.61e-05	0.000164	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	9.26e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.26e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	9.13e-05	0.000156	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.12e-05	0.000156	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	8.9e-05	0.000152	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	8.88e-05	0.000152	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.85e-05	0.000151	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.84e-05	0.000151	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.83e-05	0.000151	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	8.79e-05	0.00015	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.73e-05	0.000149	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	8.68e-05	0.000148	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	8.52e-05	0.000146	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.43e-05	0.000144	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	8.4e-05	0.000144	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	8.3e-05	0.000142	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	8.19e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	8.17e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	8.08e-05	0.000138	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.87e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	7.73e-05	0.000132	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.64e-05	0.00013	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	7.52e-05	0.000128	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.51e-05	0.000128	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	7.49e-05	0.000128	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	7.22e-05	0.000123	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	7.07e-05	0.000121	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	6.94e-05	0.000119	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.89e-05	0.000118	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	6.88e-05	0.000118	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.85e-05	0.000117	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	6.85e-05	0.000117	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.8e-05	0.000116	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.7e-05	0.000114	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	6.5e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.48e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	6.47e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	6.47e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	6.37e-05	0.000109	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	6.33e-05	0.000108	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.97e-05	0.000102	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.95e-05	0.000102	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—polycystic ovary syndrome	5.83e-05	9.97e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.78e-05	9.88e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	5.77e-05	9.87e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.57e-05	9.52e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	5.51e-05	9.42e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	5.5e-05	9.4e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	5.36e-05	9.16e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.35e-05	9.15e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	5.31e-05	9.07e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.29e-05	9.03e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	5.21e-05	8.91e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	5.06e-05	8.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.04e-05	8.61e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.99e-05	8.53e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.91e-05	8.4e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	4.86e-05	8.31e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.79e-05	8.19e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	4.5e-05	7.69e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.47e-05	7.64e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.28e-05	7.32e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.25e-05	7.27e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.14e-05	7.07e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.06e-05	6.94e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.94e-05	6.74e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.89e-05	6.65e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	3.89e-05	6.64e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	3.87e-05	6.61e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	3.79e-05	6.47e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.62e-05	6.19e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.57e-05	6.11e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.56e-05	6.08e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.47e-05	5.93e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.31e-05	5.65e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.13e-05	5.36e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.07e-05	5.25e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.03e-05	5.18e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.01e-05	5.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.92e-05	4.99e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.37e-05	4.05e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.34e-05	3.99e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.32e-05	3.97e-05	CbGpPWpGaD
